-
1
-
-
0002136462
-
Malignant bone tumors
-
United States SEER Program 1975-1999. Ries LAG, Smith MA, Gurney JG, et al. (Eds). National Institutes of Health, Bethesda, MD, USA
-
Gurney JG, Swensen AR, Bulterys M: Malignant bone tumors. In: Cancer Incidence and Survival Among Children and Adolescents. United States SEER Program 1975-1999. Ries LAG, Smith MA, Gurney JG, et al. (Eds). National Institutes of Health, Bethesda, MD, USA, 99-110 (1999).
-
(1999)
Cancer Incidence and Survival among Children and Adolescents
, pp. 99-110
-
-
Gurney, J.G.1
Swensen, A.R.2
Bulterys, M.3
-
2
-
-
57449106661
-
Ewings tumors over the age of 40: A retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G 99
-
Pieper S, Ranft A, Braun-Munzinger G, Jurgens H, Paulussen M, Dirksen U: Ewings tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99. Onkologie 31(12), 657-663 (2008).
-
(2008)
Onkologie
, vol.31
, Issue.12
, pp. 657-663
-
-
Pieper, S.1
Ranft, A.2
Braun-Munzinger, G.3
Jurgens, H.4
Paulussen, M.5
Dirksen, U.6
-
3
-
-
35548935081
-
Ewing tumours: Outcome in children, adolescents and adult patients
-
Paulussen M, Ranft A, Dirksen U, Jurgens H: Ewing tumours: outcome in children, adolescents and adult patients. Eur. J. Cancer Suppl. (5), 209-215 (2007).
-
(2007)
Eur. J. Cancer Suppl.
, vol.5
, pp. 209-215
-
-
Paulussen, M.1
Ranft, A.2
Dirksen, U.3
Jurgens, H.4
-
4
-
-
52449094980
-
Results of the EICESS-92 Study: Two randomized trials of Ewings sarcoma treatment - Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. European Intergroup Cooperative Ewings Sarcoma Study-92
-
Paulussen M, Craft AW, Lewis I, et al.: Results of the EICESS-92 Study: two randomized trials of Ewings sarcoma treatment - cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. European Intergroup Cooperative Ewings Sarcoma Study-92. J. Clin. Oncol. 26(27), 4385-4393 (2008).
-
(2008)
J. Clin. Oncol.
, vol.26
, Issue.27
, pp. 4385-4393
-
-
Paulussen, M.1
Craft, A.W.2
Lewis, I.3
-
5
-
-
66349087641
-
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Childrens Oncology Group Study
-
Granowetter L, Womer R, Devidas M, et al.: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Childrens Oncology Group Study. J. Clin. Oncol. 27(15), 2536-2541 (2009).
-
(2009)
J. Clin. Oncol.
, vol.27
, Issue.15
, pp. 2536-2541
-
-
Granowetter, L.1
Womer, R.2
Devidas, M.3
-
6
-
-
75649144053
-
The value of local treatment in patients with primary, disseminated multifocal Ewing sarcoma (PDMES)
-
Haeusler J, Ranft A, Bölling T, et al.: The value of local treatment in patients with primary, disseminated multifocal Ewing sarcoma (PDMES). Cancer 116(2), 443-450 (2010).
-
(2010)
Cancer
, vol.116
, Issue.2
, pp. 443-450
-
-
Haeusler, J.1
Ranft, A.2
Bölling, T.3
-
7
-
-
48249151771
-
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Childrens Oncology Group. Childrens Oncology Group
-
Leavey PJ, Mascarenhas L, Marina N, et al.: Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Childrens Oncology Group. Childrens Oncology Group. Pediatr. Blood Cancer 51(3), 334-338 (2008).
-
(2008)
Pediatr. Blood Cancer
, vol.51
, Issue.3
, pp. 334-338
-
-
Leavey, P.J.1
Mascarenhas, L.2
Marina, N.3
-
8
-
-
0027438827
-
Combinatorial generation of variable fusion proteins in the Ewing family of tumours
-
Zucman J, Melot T, Desmaze C, et al.: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 12(12), 4481-4487 (1993).
-
(1993)
EMBO J.
, vol.12
, Issue.12
, pp. 4481-4487
-
-
Zucman, J.1
Melot, T.2
Desmaze, C.3
-
9
-
-
77951630370
-
Impact of EWS-ETS fusion type on disease progression in Ewinǵs sarcoma/peripheral primitive neuroectodermal tumor: Prospective results from the cooperative EURO-E.W.I.N.G.99 trial
-
Le Deley MC, Delattre O, Schäfer KL, et al.: Impact of EWS-ETS fusion type on disease progression in Ewinǵs sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative EURO-E.W.I.N.G.99 trial. J. Clin. Oncol 28(12), 1982-1888 (2010).
-
(2010)
J. Clin. Oncol
, vol.28
, Issue.12
, pp. 1982-1888
-
-
Le Deley, M.C.1
Delattre, O.2
Schäfer, K.L.3
-
10
-
-
23644447581
-
Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma
-
Maksimenko A, Malvy C: Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma. Expert Opin. Ther. Targets 9(4), 825-830 (2005).
-
(2005)
Expert Opin. Ther. Targets
, vol.9
, Issue.4
, pp. 825-830
-
-
Maksimenko, A.1
Malvy, C.2
-
11
-
-
70349294051
-
Antitumor vectorized oligonucleotides in a model of ewing sarcoma: Unexpected role of nanoparticles
-
Elhamess H, Bertrand JR, Maccario J, Maksimenko A, Malvy C: Antitumor vectorized oligonucleotides in a model of ewing sarcoma: unexpected role of nanoparticles. Oligonucleotides 19(3), 255-264 (2009).
-
(2009)
Oligonucleotides
, vol.19
, Issue.3
, pp. 255-264
-
-
Elhamess, H.1
Bertrand, J.R.2
MacCario, J.3
Maksimenko, A.4
Malvy, C.5
-
12
-
-
48249127913
-
Microsatellites as EWS/FLI response elements in Ewings sarcoma
-
Gangwal K, Sankar S, Hollenhorst PC, et al.: Microsatellites as EWS/FLI response elements in Ewings sarcoma. Proc. Natl Acad. Sci. USA 105(29), 10149-10154 (2008).
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, Issue.29
, pp. 10149-10154
-
-
Gangwal, K.1
Sankar, S.2
Hollenhorst, P.C.3
-
13
-
-
65549090018
-
A molecular function map of Ewing̀s sarcoma
-
Kauer M, Nan J, Kofler R, et al.: A molecular function map of Ewing̀s sarcoma. PLoS ONE 4(e5415), 1-11 (2009).
-
(2009)
PLoS ONE
, vol.4
, Issue.5415
, pp. 1-11
-
-
Kauer, M.1
Nan, J.2
Kofler, R.3
-
14
-
-
40549086265
-
A transcriptional profiling meta-analysis reveals a core EWS-FLI1 gene expression signature
-
Hancock JD, Lessnick SL: A transcriptional profiling meta-analysis reveals a core EWS-FLI1 gene expression signature. Cell Cycle 7(2), 250-256 (2008).
-
(2008)
Cell Cycle
, vol.7
, Issue.2
, pp. 250-256
-
-
Hancock, J.D.1
Lessnick, S.L.2
-
15
-
-
65249101694
-
EZH2 is a mediator of EWS/Fli1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
-
Richter GHS, Plehm S, Fasan A, et al.: EZH2 is a mediator of EWS/Fli1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. PNAS 106(13), 5324-5329 (2009).
-
(2009)
PNAS
, vol.106
, Issue.13
, pp. 5324-5329
-
-
Ghs, R.1
Plehm, S.2
Fasan, A.3
-
16
-
-
42049089299
-
EWS-Fli1 expression triggers a Ewing sarcoma initiation program in primary human mesenchymal stem cells
-
Riggi N, Suvà ML, Suvà D, et al.: EWS-Fli1 expression triggers a Ewing sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res. 68(7), 2176-2185 (2008).
-
(2008)
Cancer Res.
, vol.68
, Issue.7
, pp. 2176-2185
-
-
Riggi, N.1
Suvà, M.L.2
Suvà, D.3
-
18
-
-
70449589299
-
GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors
-
10e7608
-
Joo J, Christensen L, Warner K, et al.: GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors. PLoS ONE 4(10e7608), 1-9 (2009).
-
(2009)
PLoS ONE
, vol.4
, pp. 1-9
-
-
Joo, J.1
Christensen, L.2
Warner, K.3
-
19
-
-
0028170817
-
Receptor protein-tyrosine kinases and their signal transduction pathways
-
van der Geer P, Hunter T, Lindberg RA: Receptor protein-tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell Biol. 10, 251-337 (1994).
-
(1994)
Ann. Rev. Cell Biol.
, vol.10
, pp. 251-337
-
-
Van Der Geer, P.1
Hunter, T.2
Lindberg, R.A.3
-
20
-
-
2342591455
-
The discovery of receptor tyrosine kinases: Targets for cancer therapy
-
Gwschind A, Fischer OM, Ullrich A: The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 4(1), 361-370 (2004). (Pubitemid 38579482)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.5
, pp. 361-370
-
-
Gschwind, A.1
Fischer, O.M.2
Ullrich, A.3
-
21
-
-
3543026281
-
EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3
-
Prieur A, Tirode F, Cohen P, Delattre O: EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 24(16), 7275-7283 (2004).
-
(2004)
Mol. Cell. Biol.
, vol.24
, Issue.16
, pp. 7275-7283
-
-
Prieur, A.1
Tirode, F.2
Cohen, P.3
Delattre, O.4
-
22
-
-
73349099049
-
Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1
-
Tolcher AW, Sarantopoulos J, Patnaik A, et al.: Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. J. Clin. Oncol. 27(34), 5800-5807 (2009).
-
(2009)
J. Clin. Oncol.
, vol.27
, Issue.34
, pp. 5800-5807
-
-
Tolcher, A.W.1
Sarantopoulos, J.2
Patnaik, A.3
-
23
-
-
70350227313
-
The insulin-like growth factor-1 receptor-targeting antibody, CP-751, 871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma
-
Kurmasheva RT, Dudkin L, Billups C, Debelenko LV, Morton CL, Houghton PJ: The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma. Cancer Res. 69(19), 7662-7671 (2009).
-
(2009)
Cancer Res.
, vol.69
, Issue.19
, pp. 7662-7671
-
-
Kurmasheva, R.T.1
Dudkin, L.2
Billups, C.3
Debelenko, L.V.4
Morton, C.L.5
Houghton, P.J.6
-
24
-
-
67650302850
-
Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchical statistical model
-
Chugh R, Wathen KJ, Maki RG, et al.: Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchical statistical model. J. Clin. Oncol. 27(7), 3148-3153 (2009).
-
(2009)
J. Clin. Oncol.
, vol.27
, Issue.7
, pp. 3148-3153
-
-
Chugh, R.1
Wathen, K.J.2
Maki, R.G.3
-
25
-
-
33847348574
-
Protein expression of KIT and gene mutation of c-Kit and PDGFRs in Ewing sarcomas
-
Do I, Araujo ES, Kalil RK, et al.: Protein expression of KIT and gene mutation of c-Kit and PDGFRs in Ewing sarcomas. Pathol. Res. Pract. 203(1), 486-492 (2007).
-
(2007)
Pathol. Res. Pract.
, vol.203
, Issue.1
, pp. 486-492
-
-
Do, I.1
Araujo, E.S.2
Kalil, R.K.3
-
26
-
-
77949740524
-
ABT-869 inhibits the proliferation of Ewing sarcoma cells and suppresses platelet-derived growth factor receptor b and c-KIT signalling pathways
-
Ikeda AK, Judelson DR, Federman N, et al.: ABT-869 inhibits the proliferation of Ewing sarcoma cells and suppresses platelet-derived growth factor receptor b and c-KIT signalling pathways. Mol. Cancer Ther. 9(3), 653-660 (2010).
-
(2010)
Mol. Cancer Ther.
, vol.9
, Issue.3
, pp. 653-660
-
-
Ikeda, A.K.1
Judelson, D.R.2
Federman, N.3
-
27
-
-
32044465506
-
TOR signalling in growth and metabolism
-
Wullschleger S, Loewith R, Hall MN: TOR signalling in growth and metabolism. Cell 124(3), 471-484 (2006).
-
(2006)
Cell
, vol.124
, Issue.3
, pp. 471-484
-
-
Wullschleger, S.1
Loewith, R.2
Hall, M.N.3
-
28
-
-
1642540093
-
Rapamycin induces the fusion-type independent downregulation of the EWS-Fli1 proteins and inhibits Ewings sarcoma cell proliferation
-
Mateo-Lozano, S, Tirado OM, Notario V: Rapamycin induces the fusion-type independent downregulation of the EWS-Fli1 proteins and inhibits Ewings sarcoma cell proliferation. Oncogene 22(3), 9282-9287 (2003).
-
(2003)
Oncogene
, vol.22
, Issue.3
, pp. 9282-9287
-
-
Mateo-Lozano, S.1
Tirado, O.M.2
Notario, V.3
-
29
-
-
67650447477
-
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewings sarcoma
-
Erkizan HV, Kong Y, Merchant M, et al.: A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewings sarcoma. Nat. Med. 15(7), 750-756 (2009).
-
(2009)
Nat. Med.
, vol.15
, Issue.7
, pp. 750-756
-
-
Erkizan, H.V.1
Kong, Y.2
Merchant, M.3
-
30
-
-
38549084557
-
Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing̀s sarcoma family of tumors
-
Roberts P, Burchill SA, Brownhill S, et al.: Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing̀s sarcoma family of tumors. Genes Chromosomes Cancer 47(4), 207-220 (2007).
-
(2007)
Genes Chromosomes Cancer
, vol.47
, Issue.4
, pp. 207-220
-
-
Roberts, P.1
Burchill, S.A.2
Brownhill, S.3
-
31
-
-
70349753195
-
Advances in Ewing̀s sarcoma research: Where are we now and what lies ahead?
-
Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J: Advances in Ewing̀s sarcoma research: where are we now and what lies ahead? Cancer Res. 69(18), 7140-7150 (2009).
-
(2009)
Cancer Res.
, vol.69
, Issue.18
, pp. 7140-7150
-
-
Ordonez, J.L.1
Osuna, D.2
Herrero, D.3
De Alava, E.4
Madoz-Gurpide, J.5
-
32
-
-
66849124862
-
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: Implications for immune recognition
-
Berghuis D, de Hooge AS, Santos SJ, et al.: Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition. J. Pathol. 218(2), 222-231 (2009).
-
(2009)
J. Pathol.
, vol.218
, Issue.2
, pp. 222-231
-
-
Berghuis, D.1
De Hooge, A.S.2
Santos, S.J.3
-
33
-
-
67650091383
-
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25(hi) FoxP3+) in Ewing sarcoma patients is associated with metastatic disease
-
Brinkrolf P, Landmeier S, Altvater B, et al.: A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25(hi) FoxP3+) in Ewing sarcoma patients is associated with metastatic disease. Int. J. Cancer 125(4), 879-886 (2009).
-
(2009)
Int. J. Cancer
, vol.125
, Issue.4
, pp. 879-886
-
-
Brinkrolf, P.1
Landmeier, S.2
Altvater, B.3
-
34
-
-
77954675158
-
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
-
Verhoeven DH, de Hooge AS, Mooiman EC, et al.: NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Pediatr. Transplant. 13(6), 746-753 (2008).
-
(2008)
Pediatr. Transplant.
, vol.13
, Issue.6
, pp. 746-753
-
-
Verhoeven, D.H.1
De Hooge, A.S.2
Mooiman, E.C.3
-
35
-
-
51049105734
-
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
-
Macall CL, Rhea EH, Read EJ, et al.: A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin. Cancer Res. 14(15), 4850-4880 (2008).
-
(2008)
Clin. Cancer Res.
, vol.14
, Issue.15
, pp. 4850-4880
-
-
MacAll, C.L.1
Rhea, E.H.2
Read, E.J.3
-
36
-
-
34447295403
-
Interferon g sensitizes resistant Ewings sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity
-
Lissat A, Vraetz T, Tsokos M, et al.: Interferon g sensitizes resistant Ewings sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity. Am. J. Pathol. 170, 1917-1930 (2007).
-
(2007)
Am. J. Pathol.
, vol.170
, pp. 1917-1930
-
-
Lissat, A.1
Vraetz, T.2
Tsokos, M.3
-
37
-
-
0037565276
-
TRAIL-induced apoptosis and interaction with cyctotoxic agents in soft tissue sarcoma cell lines
-
Tomek S, Koestler W, Horak P, et al.: TRAIL-induced apoptosis and interaction with cyctotoxic agents in soft tissue sarcoma cell lines. Eur. J. Cancer 39(2), 1318-1329 (2003).
-
(2003)
Eur. J. Cancer
, vol.39
, Issue.2
, pp. 1318-1329
-
-
Tomek, S.1
Koestler, W.2
Horak, P.3
-
38
-
-
54249107246
-
The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
-
Wang S: The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene 27(3), 6297-16215 (2008).
-
(2008)
Oncogene
, vol.27
, Issue.3
, pp. 6297-16215
-
-
Wang, S.1
-
39
-
-
29144462140
-
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewings sarcoma
-
Scotlandi K, Perdichizzi S, Bernard G, et al.: Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewings sarcoma. Eur. J. Cancer 42(1), 91-96 (2006).
-
(2006)
Eur. J. Cancer
, vol.42
, Issue.1
, pp. 91-96
-
-
Scotlandi, K.1
Perdichizzi, S.2
Bernard, G.3
-
40
-
-
0031045193
-
Interethnic polymorphism of EWS intron 6: Menome plasticity mediated by Alu reposition and recombination
-
Zucman-Rossi J, Batzer MA, Stoneking M, et al.: Interethnic polymorphism of EWS intron 6: menome plasticity mediated by Alu reposition and recombination. Hum. Genet. 99, 357-363 (1997).
-
(1997)
Hum. Genet.
, vol.99
, pp. 357-363
-
-
Zucman-Rossi, J.1
Batzer, M.A.2
Stoneking, M.3
-
41
-
-
76249093091
-
Ethnic and racial differences in patients with Ewing sarcoma
-
Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG: Ethnic and racial differences in patients with Ewing sarcoma. Cancer 2(15), 983-988 (2010).
-
(2010)
Cancer
, vol.2
, Issue.15
, pp. 983-988
-
-
Worch, J.1
Matthay, K.K.2
Neuhaus, J.3
Goldsby, R.4
Dubois, S.G.5
-
42
-
-
68149164796
-
Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome
-
Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP: Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome. Cancer 115(15), 3526-3536 (2009).
-
(2009)
Cancer
, vol.115
, Issue.15
, pp. 3526-3536
-
-
Jawad, M.U.1
Cheung, M.C.2
Min, E.S.3
Schneiderbauer, M.M.4
Koniaris, L.G.5
Scully, S.P.6
-
43
-
-
17444447915
-
Prognostic factors in nonmetastatic Ewings sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli
-
Bacci G, Ferrari S, Bertoni F, et al.: Prognostic factors in nonmetastatic Ewings sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J. Clin. Oncol. 18(1), 4-11 (2000).
-
(2000)
J. Clin. Oncol.
, vol.18
, Issue.1
, pp. 4-11
-
-
Bacci, G.1
Ferrari, S.2
Bertoni, F.3
-
44
-
-
0002550752
-
Improvement in survival for Ewing̀s sarcoma by substitution of ifosfamide for cyclophosphamide: A UKCCSG/MRC study
-
Craft AW, Cotterill S, Imeson J: Improvement in survival for Ewing̀s sarcoma by substitution of ifosfamide for cyclophosphamide: a UKCCSG/MRC study. Am. J. Pediatr. Hematol. Oncol. 15(1), 31-35 (1993).
-
(1993)
Am. J. Pediatr. Hematol. Oncol.
, vol.15
, Issue.1
, pp. 31-35
-
-
Craft, A.W.1
Cotterill, S.2
Imeson, J.3
-
45
-
-
7144261049
-
Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies
-
Paulussen M, Ahrens S, Burdach S, et al.: Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann. Oncol. 9, 275-281 (1998).
-
(1998)
Ann. Oncol.
, vol.9
, pp. 275-281
-
-
Paulussen, M.1
Ahrens, S.2
Burdach, S.3
|